Gilead's HIV portfolio remains dominant but faces Medicare Part D pricing pressure, limiting future growth potential. New launches like Livdelzi provide growth opportunities but are unlikely to ...

The FDA has placed a partial clinical fold on clinical trials of Gilead Sciences' magrolimab, the centre piece of its $4.9 billion acquisition of Forty Seven in 2020.

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The perfect products for a glow up. View Entire Post › ...

After hours: March 20 at 7:49:43 PM EDT Loading Chart for GILD ...

Vaginal tears are cuts that occur in vaginal tissues, both inside the body and externally. Symptoms include pain, bleeding, swelling, bruising, and problems sitting or walking. Tears range in severity ...

After hours: March 17 at 7:50:53 PM EDT ...